Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus
- Status
- COMPLETED
- Phase
- PHASE1
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
- Status
- COMPLETED
- Phase
- PHASE3
Robotic-assisted Esophagectomy vs. Video-Assisted Thoracoscopic Esophagectomy(REVATE) Trial
- Status
- UNKNOWN
- Phase
- NA
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
- Status
- COMPLETED
- Phase
- PHASE2
Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin
- Status
- UNKNOWN
- Phase
- PHASE3
Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
NCI UNC Project ESCC
- Status
- TERMINATED
- Phase
- N/A